In summary, the work presented here identifies a resource comprising proteomic regulation in the PTC tumor and circulation, highlights that integrin-mediated pathways as well as complement activation and coagulation cascades are regulated, and distinguishes FN1, GSN and GALE as promising biomarkers to achieve the diagnostics for indeterminate cases. The gene discussed is FN1; the disease is neoplasm.